Yasuyuki Miyake
Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantation
BackgroundT cells derived from gene-edited induced pluripotent stem cells (iPSCs) are a promising alternative cell source for universal T-cell immunotherapy. However, current preclinical evaluations of iPSC-derived T cells (iPSC-T cells) rely on immuno…